Cargando…

Immunogenicity and safety of vaccination in children with paediatric rheumatic diseases: a scoping review

Children with paediatric rheumatic diseases (PRDs) are at increased risk of vaccine-preventable disease. Safe and effective vaccination is central to preventive care in PRD patients; however, uncertainty surrounding immunogenicity and safety has contributed to suboptimal vaccination. The aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cunninghame, Jacqueline, Wen, Sophie, Dufficy, Mitchell, Ullman, Amanda, Takashima, Mari, Cann, Megan, Doyle, Rebecca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131534/ https://www.ncbi.nlm.nih.gov/pubmed/37124959 http://dx.doi.org/10.1177/25151355231167116

Ejemplares similares

Extravasation injury management for neonates and children: A systematic review and aggregated case series
por: Dufficy, Mitchell, et al.
Publicado: (2022)

Safety and immunogenicity of human papillomavirus vaccination in juvenile patients with rheumatic diseases
por: Heijstek, MW, et al.
Publicado: (2011)

Immunogenicity and safety of primary fractional-dose yellow fever vaccine in autoimmune rheumatic diseases
por: Tonacio, Adriana Coracini, et al.
Publicado: (2021)

Randomized controlled trials in central vascular access devices: A scoping review
por: Takashima, Mari, et al.
Publicado: (2017)

Yellow fever vaccination in Brazil: Short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases
por: Emi Aikawa, Nádia, et al.
Publicado: (2021)

Immunogenicity and safety of routine vaccines in children and adolescents with rheumatic diseases on immunosuppressive treatment — a systematic review
por: Keller, Michèle, et al.
Publicado: (2021)

Immunogenicity, Effectiveness, and Safety of COVID-19 Vaccines in Rheumatic Patients: An Updated Systematic Review and Meta-Analysis
por: Tang, Kuo-Tung, et al.
Publicado: (2022)

Safety and immunogenicity of inactivated COVID-19 vaccination in adult rheumatic patients in South China: a prospective study
por: Zeng, Huiqiong, et al.
Publicado: (2022)

Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients
por: Pri-Paz Basson, Yael, et al.
Publicado: (2022)

Spectrum of paediatric rheumatic diseases in Nigeria
por: Olaosebikan, Babatunde Hakeem, et al.
Publicado: (2017)

Immunogenicity of inactivated COVID-19 vaccine in patients with autoimmune inflammatory rheumatic diseases
por: Zheng, Yi-Qing, et al.
Publicado: (2022)

Effects of biological and non-biological immunomodulatory therapies on the immunogenicity of vaccines in patients with rheumatic diseases
por: McMahan, Zsuzsanna H, et al.
Publicado: (2014)

Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases
por: Arumahandi de Silva, Amanthi Nadira, et al.
Publicado: (2022)

Disease Activity Measures in Paediatric Rheumatic Diseases
por: Luca, Nadia J., et al.
Publicado: (2013)

Immunogenicity and Efficacy Evaluation of Subunit Astrovirus Vaccines
por: Bidokhti, Mehdi R.M., et al.
Publicado: (2019)

Immunogenicity and safety of the BBIBP‐CorV vaccine in patients with autoimmune inflammatory rheumatic diseases undergoing immunosuppressive therapy in a monocentric cohort
por: Zamani, Batool, et al.
Publicado: (2023)

Immunogenicity and safety of the CoronaVac and BNT162b2 Covid-19 vaccine in patients with inflammatory rheumatic diseases and healthy adults: comparison of different vaccines
por: Batıbay, Sevilay, et al.
Publicado: (2022)

Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations
por: Rondaan, Christien, et al.
Publicado: (2019)

Drug Safety in Translational Paediatric Research: Practical Points to Consider for Paediatric Safety Profiling and Protocol Development: A Scoping Review
por: Aurich, Beate, et al.
Publicado: (2021)

Immunogenicity and Safety of Diphtheria-tetanus Vaccine in Adults
por: Choi, Jung-Hyun, et al.
Publicado: (2010)

A Systematic Review and Meta-Analysis of Anti-Rheumatic Drugs and Pneumococcal Vaccine Immunogenicity in Inflammatory Arthritis
por: Nagra, Deepak, et al.
Publicado: (2023)

Immunogenicity and safety among laboratory workers vaccinated with Bexsero® vaccine
por: Hong, Eva, et al.
Publicado: (2016)

Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine administered concomitantly with other paediatric vaccines in toddlers: a phase III randomised study
por: Dhingra, M. S., et al.
Publicado: (2021)

B Cells as a Therapeutic Target in Paediatric Rheumatic Disease
por: Wilkinson, Meredyth G. Ll, et al.
Publicado: (2019)

Spectrum of paediatric rheumatic disorders at a tertiary hospital in Tanzania
por: Furia, Francis F., et al.
Publicado: (2020)

COVID-19 Vaccine in Immunosuppressed Adults with Autoimmune rheumatic Diseases (COVIAAD): safety, immunogenicity and antibody persistence at 12 months following Moderna Spikevax primary series
por: Colmegna, Ines, et al.
Publicado: (2023)

Quality improvement project aimed at integrating an adapted mindfulness-based stress reduction programme into a paediatric psychology service
por: Doyle, Jacqueline, et al.
Publicado: (2019)

Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis
por: Kapetanovic, Meliha C, et al.
Publicado: (2014)

Immunogenicity and safety of subunit influenza vaccines in pregnant women
por: Kostinov, Mikhail P., et al.
Publicado: (2018)

Safety and immunogenicity of synchronous COVID19 and influenza vaccination
por: Baj, Andreina, et al.
Publicado: (2022)

Immunogenicity and Safety of Beta-Adjuvanted Recombinant Booster Vaccine
por: Launay, Odile, et al.
Publicado: (2022)

Immunogenicity and safety of coadministration of COVID-19 and influenza vaccination
por: Wagenhäuser, Isabell, et al.
Publicado: (2023)

Safety and immunogenicity of COVID-19 vaccination in immunocompromised patients
por: Song, Jin-Wen, et al.
Publicado: (2022)

Safety, Tolerability, and Immunogenicity of COVID-19 Bivalent Vaccination
por: Saxena, Divyasha, et al.
Publicado: (2023)

SHARE – workpackage 5: development of best practices of diagnosis and treatment for paediatric rheumatic diseases throughout Europe
por: Vastert, Sebastiaan, et al.
Publicado: (2014)

Facilitators and barriers of vaccine uptake in patients with autoimune inflammatory rheumatic disease: a scoping review
por: Neusser, Silke, et al.
Publicado: (2022)

Efficacy, Immunogenicity and Safety of Vaccination in Pediatric Patients With Autoimmune Inflammatory Rheumatic Diseases (pedAIIRD): A Systematic Literature Review for the 2021 Update of the EULAR/PRES Recommendations
por: Jansen, Marc H., et al.
Publicado: (2022)

Comparison of ultrasound‐guided peripheral intravenous catheter insertion with landmark technique in paediatric patients: A systematic review and meta‐analysis
por: Kleidon, Tricia M, et al.
Publicado: (2022)

Breastfeeding in women with rheumatic diseases
por: Ikram, Naira, et al.
Publicado: (2021)

Confidence amongst Multidisciplinary Professionals in Managing Paediatric Rheumatic Disease in Australia
por: Cassidy, Samuel, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tghj4j84mmtaobeg97cj680959